REQUEST A DEMO
Total
USD $0.00
Search more companies

Innoquest Pathology Sdn. Bhd. (Malaysia)

Main Activities: Medical Laboratories
Full name: Innoquest Pathology Sdn. Bhd. Profile Updated: October 16, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Innoquest Pathology Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Petaling Jaya. The company operates in the Medical Laboratories sector. The company was established on December 30, 1985. In 2021, the company reported a net sales revenue increase of 76.09%. Its’ total assets recorded a growth of 260.31%. In 2021, Innoquest Pathology Sdn. Bhd.’s net profit margin increased by 13.72%.

Headquarters
2Nd Floor, Wisma Tecna 18A Jalan 51A/223 46100 Petaling Jaya Selangor
Petaling Jaya; Selangor; Postal Code: 46100

Contact Details: Purchase the Innoquest Pathology Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Innoquest Pathology Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Innoquest Pathology Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Innoquest Pathology Sdn. Bhd. report to view the information.
Incorporation Date:
December 30, 1985
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Gribbles Cytology Services Sdn. Bhd.
100%
Gribbles Environmental Health Services Sdn. Bhd.
100%
Gribbles Veterinary Services Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Innoquest Pathology Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
76.09%
Total operating revenue
76.09%
Operating profit (EBIT)
296.86%
Net Profit (Loss) for the Period
316.38%
Total assets
260.31%
Total equity
143.4%
Operating Profit Margin (ROS)
17.5%
Net Profit Margin
13.72%
Return on Equity (ROE)
24.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?